Labcorp Receivables 2010-2024 | LH

Labcorp receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Labcorp receivables for the quarter ending September 30, 2024 were $2.225B, a 7.74% increase year-over-year.
  • Labcorp receivables for 2023 were $2.099B, a 5.08% increase from 2022.
  • Labcorp receivables for 2022 were $1.997B, a 32.94% decline from 2021.
  • Labcorp receivables for 2021 were $2.978B, a 1.27% decline from 2020.
Labcorp Annual Receivables
(Millions of US $)
2023 $2,099
2022 $1,997
2021 $2,978
2020 $3,017
2019 $2,025
2018 $1,862
2017 $1,848
2016 $1,519
2015 $1,375
2014 $816
2013 $785
2012 $719
2011 $700
2010 $656
2009 $574
Labcorp Quarterly Receivables
(Millions of US $)
2024-09-30 $2,225
2024-06-30 $2,246
2024-03-31 $2,204
2023-12-31 $2,099
2023-09-30 $2,065
2023-06-30 $2,043
2023-03-31 $3,050
2022-12-31 $1,997
2022-09-30 $2,983
2022-06-30 $3,044
2022-03-31 $3,040
2021-12-31 $2,978
2021-09-30 $3,055
2021-06-30 $2,847
2021-03-31 $2,903
2020-12-31 $3,017
2020-09-30 $2,699
2020-06-30 $2,196
2020-03-31 $1,960
2019-12-31 $2,025
2019-09-30 $2,094
2019-06-30 $2,065
2019-03-31 $1,986
2018-12-31 $1,862
2018-09-30 $1,856
2018-06-30 $1,872
2018-03-31 $1,962
2017-12-31 $1,848
2017-09-30 $1,824
2017-06-30 $1,627
2017-03-31 $1,578
2016-12-31 $1,519
2016-09-30 $1,563
2016-06-30 $1,518
2016-03-31 $1,500
2015-12-31 $1,375
2015-09-30 $1,397
2015-06-30 $1,365
2015-03-31 $1,351
2014-12-31 $816
2014-09-30 $842
2014-06-30 $833
2014-03-31 $822
2013-12-31 $785
2013-09-30 $813
2013-06-30 $816
2013-03-31 $794
2012-12-31 $719
2012-09-30 $769
2012-06-30 $736
2012-03-31 $752
2011-12-31 $700
2011-09-30 $719
2011-06-30 $715
2011-03-31 $717
2010-12-31 $656
2010-09-30 $631
2010-06-30 $618
2010-03-31 $614
2009-12-31 $574
2009-09-30 $637
2009-06-30 $655
2009-03-31 $669
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.088B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49